{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T12:38:49Z","timestamp":1793709529574,"version":"4.6.1"},"reference-count":15,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T00:00:00Z","timestamp":1783468800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","lipidjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Lipidology"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.jacl.2026.07.009","type":"journal-article","created":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T23:40:19Z","timestamp":1783640419000},"page":"1863-1869","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Predicting genetically defined familial hypercholesterolemia with the FAMCAT algorithm in an Australian tertiary clinic"],"prefix":"10.1016","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4529-8237","authenticated-orcid":false,"given":"Ralph K.","family":"Akyea","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dick C.","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9700-6948","authenticated-orcid":false,"given":"Jing","family":"Pang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyed Saeed Tamehri","family":"Zadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9720-1180","authenticated-orcid":false,"given":"Barbara","family":"Iyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadeem","family":"Qureshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerald","family":"Watts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacl.2026.07.009_bib1","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1038\/s41569-023-00892-0","article-title":"International Atherosclerosis Society guidance for implementing best practice in the care of familial hypercholesterolaemia","volume":"20","author":"Watts","year":"2023","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.jacl.2026.07.009_bib2","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/0002-9149(93)90155-6","article-title":"Diagnosing heterozygous familial hypercholesterolemia using new practical criteria validated by molecular genetics","volume":"72","author":"Williams","year":"1993","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacl.2026.07.009_bib3","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.atherosclerosis.2014.12.034","article-title":"Improving identification of familial hypercholesterolaemia in primary care: derivation and validation of the familial hypercholesterolaemia case ascertainment tool (FAMCAT)","volume":"238","author":"Weng","year":"2015","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jacl.2026.07.009_bib4","doi-asserted-by":"crossref","first-page":"e256","DOI":"10.1016\/S2468-2667(19)30061-1","article-title":"Detection of familial hypercholesterolaemia: external validation of the FAMCAT clinical case-finding algorithm to identify patients in primary care","volume":"4","author":"Weng","year":"2019","journal-title":"Lancet Public Health"},{"key":"10.1016\/j.jacl.2026.07.009_bib5","doi-asserted-by":"crossref","DOI":"10.1136\/openhrt-2021-001752","article-title":"Comparing the performance of the novel FAMCAT algorithms and established case-finding criteria for familial hypercholesterolaemia in primary care","volume":"8","author":"Qureshi","year":"2021","journal-title":"Open Heart"},{"key":"10.1016\/j.jacl.2026.07.009_bib6","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.ijcard.2015.08.146","article-title":"Elevated lipoprotein(a), hypertension and renal insufficiency as predictors of coronary artery disease in patients with genetically confirmed heterozygous familial hypercholesterolemia","volume":"201","author":"Chan","year":"2015","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jacl.2026.07.009_bib7","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1210\/jc.2017-02622","article-title":"A comparative analysis of phenotypic predictors of mutations in familial hypercholesterolemia","volume":"103","author":"Chan","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jacl.2026.07.009_bib8","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.atherosclerosis.2012.07.030","article-title":"Genetic analysis of familial hypercholesterolaemia in Western Australia","volume":"224","author":"Hooper","year":"2012","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jacl.2026.07.009_bib9","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1093\/clinchem\/18.6.499","article-title":"Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge","volume":"18","author":"Friedewald","year":"1972","journal-title":"Clin Chem"},{"key":"10.1016\/j.jacl.2026.07.009_bib10","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.atherosclerosis.2015.03.003","article-title":"Clinical experience of scoring criteria for Familial Hypercholesterolaemia (FH) genetic testing in Wales","volume":"240","author":"Haralambos","year":"2015","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jacl.2026.07.009_bib11","first-page":"632","article-title":"Clinical and genetic diagnosis of familial hypercholesterolaemia in patients undergoing coronary angiography: the Ludwigshafen Risk and Cardiovascular Health Study","volume":"10","author":"Molnar","year":"2024","journal-title":"Eur\u00a0Heart J\u00a0Qual\u00a0Care\u00a0Clin\u00a0Outcomes"},{"key":"10.1016\/j.jacl.2026.07.009_bib12","first-page":"578","article-title":"Electronic health record-based facilitation of familial hypercholesterolaemia detection: sensitivity of different algorithms in genetically confirmed patients","volume":"3","author":"Mohammadnia","year":"2022","journal-title":"Eur\u00a0Heart J\u00a0Digit\u00a0Health"},{"key":"10.1016\/j.jacl.2026.07.009_bib13","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.1136\/heartjnl-2021-319742","article-title":"Case-finding and genetic testing for familial hypercholesterolaemia in primary care","volume":"107","author":"Qureshi","year":"2021","journal-title":"Heart"},{"key":"10.1016\/j.jacl.2026.07.009_bib14","doi-asserted-by":"crossref","first-page":"330","DOI":"10.3390\/jpm12030330","article-title":"Cost-effectiveness of screening algorithms for familial hypercholesterolaemia in primary care","volume":"12","author":"Jones","year":"2022","journal-title":"J Pers Med"},{"key":"10.1016\/j.jacl.2026.07.009_bib15","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgph.0001795","article-title":"A comparison of the Netherlands, Norway and UK familial hypercholesterolemia screening programmes with implications for target setting and the UK\u2019s NHS long-term plan","volume":"3","author":"Page","year":"2023","journal-title":"PLoS Global Public Health"}],"container-title":["Journal of Clinical Lipidology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S193328742600437X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S193328742600437X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T12:19:40Z","timestamp":1793708380000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S193328742600437X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":15,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S193328742600437X"],"URL":"https:\/\/doi.org\/10.1016\/j.jacl.2026.07.009","relation":{},"ISSN":["1933-2874"],"issn-type":[{"value":"1933-2874","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Predicting genetically defined familial hypercholesterolemia with the FAMCAT algorithm in an Australian tertiary clinic","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Lipidology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacl.2026.07.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc. on behalf of National Lipid Association.","name":"copyright","label":"Copyright"}]}}